---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-026946"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:14:43.235251+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Rocket Pharmaceuticals cuts workforce 30%, extends cash runway into Q2 2027

## Summary
- Reduction in workforce of ~30%; expected to cut 12-month operating expenses by ~25%.
- Estimated $3.5M in restructuring charges in H2 2025; severance for ~80 employees.
- Board approved Plan on June 18, 2025; RIF began July 23, to be completed by August 8, 2025.
- Restructuring aims to maximize near-term value and extend operational runway into Q2 2027.

## SEC filing metadata
- accession: 0001140361-25-026946
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036125026946/0001140361-25-026946-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036125026946/ef20052517_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-026946
- JSON: https://secwatch.observer/filing/0001140361-25-026946.json
- Plain text: https://secwatch.observer/filing/0001140361-25-026946.txt

## Source-grounded claims
- claim_id: 15b573e45626cbddad57d457522c94bc485adce6
  claim: ROCKET PHARMACEUTICALS, INC. announced a restructuring with charges of approximately $3.5 million (approximately 30%).
  evidence_excerpt: The Company began notifying affected employees on July 23, 2025, and expects the RIF to be completed by August 8, 2025. The Company estimates that it will incur approximately $3.5 million in restructuring and restructuring-related charges in the second half of 2025 in connection with the Plan, consisting primarily of employee severance payments and other
  evidence_url: https://www.sec.gov/Archives/edgar/data/1281895/000114036125026946/0001140361-25-026946-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.